| |
| |
| Exchange: |
New York Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
1,310,000,000 |
| Market
Cap: |
73.32(B) |
| Last
Volume: |
16,616,000 |
Avg
Vol: |
7,672,242 |
| 52
Week Range: |
$55.15 - $81.42 |
|
| Level
I Sector: |
Consumer Discretionary |
| Level
II Sector: |
Retail |
| Level
III Sector: |
Drug Stores |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
| |
S&P 500 |
|
Rankings:
|
|
| Insider 3 Months : 10.7 |
| Insider 6 Months : 10.7 |
| Insider 3/6 Months : 21.5 |
|
| Guru Rank Number : 214 |
| Guru Rank Value : 5.7 |
| Guru Occurances : 5 |
|
|
|
|
|
| |
|
Company Profile CVS Health is a health solutions company. Co.'s segments include:Health Care Benefits, which provides voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, and dental and behavioral health plans; Pharmacy Services, which provides pharmacy benefit management solutions, including plan design offerings and administration, formulary management, and retail pharmacy network management services; and Retail/Long-Term Care (LTC), which sells prescription drugs and various health and wellness products and general merchandise, provides health care services through its MinuteClinic® walk-in medical clinics and conducts LTC pharmacy operations.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
10,181 |
10,181 |
12,181 |
26,181 |
| Total Buy Value |
$554,173 |
$554,173 |
$695,103 |
$1,671,670 |
| Total People Bought |
2 |
2 |
2 |
3 |
| Total Buy Transactions |
2 |
2 |
3 |
4 |
| Total Shares Sold |
29,473 |
29,473 |
55,232 |
484,338 |
| Total Sell Value |
$2,267,947 |
$2,267,947 |
$4,197,951 |
$46,038,227 |
| Total People Sold |
1 |
1 |
2 |
5 |
| Total Sell Transactions |
1 |
1 |
2 |
7 |
| End Date |
2024-02-04 |
2023-11-03 |
2023-05-05 |
2022-05-05 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Rohan Karen |
President and CEO |
• • – |
2024-02-12 |
4 |
A |
$0.00 |
$0 |
D/D |
136,640 |
136,640 |
|
- |
|
| Clark James David |
SVP, Cont & Chief Acct Officer |
• • – |
2024-02-12 |
4 |
A |
$0.00 |
$0 |
D/D |
2,452 |
7,150 |
|
- |
|
| Havanec Laurie P. |
EVP and Chief People Officer |
• • – |
2024-02-12 |
4 |
A |
$0.00 |
$0 |
D/D |
16,817 |
37,203 |
|
- |
|
| Shah Prem S |
EVP and Pres-Pharm, Consumer W |
• • – |
2024-02-12 |
4 |
A |
$0.00 |
$0 |
D/D |
13,313 |
69,238 |
|
- |
|
| Chaguturu Sreekanth K |
EVP and Chief Medical Officer |
• • – |
2024-02-12 |
4 |
A |
$0.00 |
$0 |
D/D |
1,926 |
8,645 |
|
- |
|
| Clark James David |
SVP, Cont & Chief Acct Officer |
• • – |
2023-12-14 |
4 |
D |
$68.48 |
$8,355 |
D/D |
(122) |
8,760 |
|
- |
|
| Finucane Anne A. |
Director |
• • – |
2023-12-07 |
4 |
GD |
$74.28 |
$256,266 |
D/D |
3,450 |
7,232 |
|
- |
|
| Cowhey Thomas F. |
SVP, Interim CFO |
• • – |
2023-11-30 |
4 |
A |
$67.95 |
$499,976 |
D/D |
7,358 |
60,938 |
|
- |
|
| Balser Jeffrey R. |
Director |
• • – |
2023-11-15 |
4 |
A |
$69.13 |
$125,609 |
D/D |
1,817 |
5,093 |
|
- |
|
| Mahoney Michael F |
Director |
• • – |
2023-11-15 |
4 |
A |
$69.13 |
$125,609 |
D/D |
1,817 |
1,817 |
|
- |
|
| Deparle Nancy Ann |
Director |
• • – |
2023-11-15 |
4 |
A |
$69.13 |
$133,075 |
D/D |
1,925 |
29,524 |
|
- |
|
| Millon Jean Pierre |
Director |
• • – |
2023-11-15 |
4 |
A |
$69.13 |
$133,075 |
D/D |
1,925 |
3,362 |
|
- |
|
| Finucane Anne A. |
Director |
• • – |
2023-11-15 |
4 |
A |
$69.13 |
$133,075 |
D/D |
1,925 |
10,682 |
|
- |
|
| Kirby J Scott |
Director |
• • – |
2023-11-15 |
4 |
A |
$69.13 |
$167,433 |
D/D |
2,422 |
2,721 |
|
- |
|
| Aguirre Fernando |
Director |
• • – |
2023-11-15 |
4 |
A |
$69.13 |
$138,122 |
D/D |
1,998 |
32,176 |
|
- |
|
| Ludwig Edward J |
Director |
• • – |
2023-11-03 |
4 |
B |
$70.47 |
$140,930 |
D/D |
2,000 |
20,630 |
2.39 |
10% |
|
| Cowhey Thomas F. |
SVP, Interim CFOOfficer |
• – – |
2023-10-13 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
53,580 |
|
8% |
|
| Cowhey Thomas F. |
SVP, Interim CFOOfficer |
• – – |
2023-10-13 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
14,977 |
|
8% |
|
| Kirby J Scott |
Director |
• • – |
2023-10-02 |
4 |
A |
$69.82 |
$20,876 |
D/D |
299 |
299 |
|
- |
|
| Kane Brian A |
EVP/President, AetnaOfficer |
• – – |
2023-09-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
910 |
|
20% |
|
| Mandadi Tilak |
EVP, Chief Technology Officer |
• • – |
2023-08-31 |
4 |
D |
$65.17 |
$850,664 |
D/D |
(13,053) |
20,229 |
|
- |
|
| Clark James David |
SVP, Cont & Chief Acct Officer |
• • – |
2023-08-03 |
4 |
S |
$74.79 |
$1,930,004 |
D/D |
(25,759) |
4,698 |
|
1% |
|
| Aguirre Fernando |
Director |
• • – |
2023-05-18 |
4 |
A |
$69.31 |
$92,113 |
D/D |
1,329 |
30,178 |
|
- |
|
| Balser Jeffrey R. |
Director |
• • – |
2023-05-18 |
4 |
A |
$69.31 |
$92,113 |
D/D |
1,329 |
3,276 |
|
- |
|
| Millon Jean Pierre |
Director |
• • – |
2023-05-18 |
4 |
A |
$69.31 |
$99,598 |
D/D |
1,437 |
1,437 |
|
- |
|
1578 Records found
|
|
Page 2 of 64 |
|
|
0.07 (0.13%) 
